Village Farms International, Inc. - Common Shares (VFF)

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The cannabis industry is notoriously rocky, but Village Farms International has earned a "buy" rating thanks to growth prospects, rising cash flow, and more.

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Investor Summit Group, an independent organization focused on creating networking opportunities for the MicroCap and SmallCap community, has announced that presentations from the August 20 Microcap Investor Summit Virtual 2024 Conference are now accessible for on-demand viewing.

RALEIGH, NC / ACCESSWIRE / June 21, 2024 / iAccess Alpha's "Buyside Best Ideas Virtual Summer Conference" is taking place on June 25-26, 2024.

The cannabis industry has come along way since Colorado made history in 2012 by legalizing recreational cannabis. New York joined 20 states in legalizing recreational marijuana use in March 2021, but has just began issuing its first 36 cannabis dispensary licences, the majority of the businesses are owned by people who have been disproportionately impacted … Continue reading "New York Issues 36 Licences for Legal Marijuana Dispensaries"

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – August 23, 2022 – The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare […]

Palm Beach, FL – November 1, 2022 – FinancialNewsMedia.com News Commentary:   The legal cannabis business is expected to generate billions of dollars as Investor confidence has grown as more countries legalize cannabis and use rises. According to Emergen Research, a recent study, 141 million Americans, or 43 percent of the adult population, use legalized cannabis. […]

Palm Beach, FL – April 14, 2021 – The medical cannabis market has made some remarkable accomplishments in the past few years with the launch of innovative products. The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based pharmaceuticals. The market for cannabis pharmaceutical is still in the nascent phase with higher opportunities. The growing legalization of marijuana globally is encouraging more investment in the space, and for pharmaceutical companies to expend more resources on the development of cannabinoid-based pharmaceutical drugs. A report from Grand View Research projected that the global cannabis pharmaceuticals market size was valued at USD 67.0 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 76.8% from 2020 to 2027.  The report said: “The rapidly progressing transformation of cannabis from herbal preparations to prescription drugs is anticipated to boost the growth of the market. Furthermore, the growing use of cannabis-based pharmaceuticals for multiple indications including inflammation, chronic pain, epilepsy, sleep disorders, anorexia, schizophrenia, and symptoms of multiple sclerosis, is another major factor driving the growth of the market. Emergence of Cannabis 3.0 that essentially highlights the necessity of value-based outcomes rather than perception based outcomes. This concept revolves around a shift from the traditional approach of smoking whole cannabis flower/bud to the consumption of processed, quantified, and packaged products derived from cannabis.”   Active Cannabis companies in the markets this week include Ikänik Farms, Inc. (CSE: IKNK.U), Cresco Labs (OTCQX:CRLBF) (CSE:CL), Village Farms International, Inc.  (NASDAQ: VFF) (TSX: VFF), Aphria Inc. (NASDAQ: APHA) (TSX: APHA), Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI).

Palm Beach, FL – August 19, 2021 – FinancialNewsMedia.com News Commentary – In the CBD market, biomass is a term that not all fully known by all. Industrial hemp biomass, sometimes referred to as fiber biomass, can be used in a variety of ways, from producing clothing to fueling machinery. However, this industrial biomass generally has lower levels of CBD, and is therefore not as useful in the production of CBD products. Alternatively, CBD biomass refers to excess hemp plant material that is rich in CBD. This kind of biomass is best used to extract CBD oils, distillate, or isolate. The resulting solution can then be used for the production of virtually any CBD products, from lotions to edibles. Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth. The global cannabidiol market size is expected to reach USD 13.4 billion by 2028, according to a new study by Grand View Research, Inc.  The report said that: “In 2020, the hemp segment accounted for the largest revenue share valued at USD $1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries.  Active companies in the markets this week include:  CAN B CORP. (OTCQB: CANB), MedMen Enterprises Inc.  (OTCQX: MMNFF) (CSE: MMEN), Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF).

On April 7th, Roth is hosting a Virtual Cannabis Day designed to provide access to the top U.S. and global public and private cannabis operators, including the leading MSOs. The team is scheduling 1-on-1/small group meetings for institutional investors to meet with leading health and wellness companies. In addition, the day will be highlighted by a panel on Cannabis Brands with the leading brand innovators. Please contact your Roth sales representative if you would like to attend.